"Monitoring, Immunologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Testing of immune status in the diagnosis and therapy of cancer, immunoproliferative and immunodeficiency disorders, and autoimmune abnormalities. Changes in immune parameters are of special significance before, during and following organ transplantation. Strategies include measurement of tumor antigen and other markers (often by RADIOIMMUNOASSAY), studies of cellular or humoral immunity in cancer etiology, IMMUNOTHERAPY trials, etc.
| Descriptor ID |
D015166
|
| MeSH Number(s) |
E01.370.225.812.505 E01.370.520.505 E05.200.812.505 E05.478.594.550
|
| Concept/Terms |
Monitoring, Immunologic- Monitoring, Immunologic
- Immunologic Monitoring
- Monitoring, Immunological
- Immunological Monitoring
- Immune Monitoring
- Monitoring, Immune
- Immunosurveillance
Radioimmunologic Monitoring- Radioimmunologic Monitoring
- Monitoring, Radioimmunological
- Radioimmunological Monitoring
- Monitoring, Radioimmunologic
|
Below are MeSH descriptors whose meaning is more general than "Monitoring, Immunologic".
Below are MeSH descriptors whose meaning is more specific than "Monitoring, Immunologic".
This graph shows the total number of publications written about "Monitoring, Immunologic" by people in this website by year, and whether "Monitoring, Immunologic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2010 | 0 | 2 | 2 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2020 | 0 | 2 | 2 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Monitoring, Immunologic" by people in Profiles.
-
Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. Commun Biol. 2022 11 04; 5(1):1181.
-
Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasis. Nat Cancer. 2020 07; 1(7):709-722.
-
Toward Functional Immune Monitoring in Allogeneic Stem Cell Transplant Recipients. Biol Blood Marrow Transplant. 2020 05; 26(5):911-919.
-
Evidence for abnormal cytokine expression in Gulf War Illness: A preliminary analysis of daily immune monitoring data. BMC Immunol. 2015 Sep 30; 16:57.
-
Left atrial thrombus mimicking a myxoma in a patient with systemic lupus erythematosus. Hellenic J Cardiol. 2014 Mar-Apr; 55(2):167-70.
-
Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab. PLoS One. 2014; 9(2):e87705.
-
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma. J Clin Oncol. 2011 Jan 20; 29(3):330-6.
-
Role of type 1 IFNs in antiglioma immunosurveillance--using mouse studies to guide examination of novel prognostic markers in humans. Clin Cancer Res. 2010 Jul 01; 16(13):3409-19.
-
Repetitive noninvasive monitoring of HSV1-tk-expressing T cells intravenously infused into nonhuman primates using positron emission tomography and computed tomography with 18F-FEAU. Mol Imaging. 2009 Jul-Aug; 8(4):230-7.
-
Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood. 2006 Feb 15; 107(4):1688-95.